InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

- Current share price for IDX : $2.250

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$839 Dividend/Distribution - IDX 17 Feb 2023 8:17AM $3.140 $2.250 fallen by 28.34%
$839 Half Yearly Report and Accounts 17 Feb 2023 8:17AM $3.140 $2.250 fallen by 28.34%
$839 Update - IDX FY23 Half Year Results Release Date 16 Feb 2023 1:57PM $3.110 $2.250 fallen by 27.65%
$839 Notification of cessation of securities - IDX 20 Jan 2023 3:22PM $3.250 $2.250 fallen by 30.77%
$839 Change in substantial holding 16 Jan 2023 11:49AM $3.230 $2.250 fallen by 30.34%
$839 FY23 IDX Half Year Results Release Date and Conference Call 11 Jan 2023 10:51AM $3.095 $2.250 fallen by 27.30%
$839 Imaging Queensland Earn Out Update 5 Dec 2022 8:45AM $2.710 $2.250 fallen by 16.97%
$839 Change of Director's Interest Notice - Jacqueline Milne 9 Nov 2022 11:36AM $2.800 $2.250 fallen by 19.64%
$839 Change of Director's Interest Notice - Ian Kadish 8 Nov 2022 3:21PM $2.830 $2.250 fallen by 20.49%
$839 Notification regarding unquoted securities - IDX 8 Nov 2022 3:02PM $2.830 $2.250 fallen by 20.49%
$839 Change in substantial holding - IDX 8 Nov 2022 12:12PM $2.810 $2.250 fallen by 19.93%
$839 Results of Annual General Meeting 4 Nov 2022 12:52PM $2.710 $2.250 fallen by 16.97%
$839 AGM Address and Presentation by Chair and CEO 4 Nov 2022 8:21AM $2.720 $2.250 fallen by 17.28%
$839 Release from Escrow 24 Oct 2022 2:04PM $2.590 $2.250 fallen by 13.13%
$839 Cancel - Proposed issue of securities - IDX 24 Oct 2022 8:27AM $2.580 $2.250 fallen by 12.79%
$839 Termination of acquisition of Exact Radiology 24 Oct 2022 8:10AM $2.580 $2.250 fallen by 12.79%
$839 Change in substantial holding 13 Oct 2022 8:17AM $2.620 $2.250 fallen by 14.12%
$839 Change of Director's Interest Notice - John Atkin 10 Oct 2022 1:18PM $2.650 $2.250 fallen by 15.09%
$839 Application for quotation of securities - IDX 5 Oct 2022 11:28AM $2.780 $2.250 fallen by 19.06%
$839 Becoming a substantial holder 4 Oct 2022 4:39PM $2.660 $2.250 fallen by 15.41%
$839 Notice of Annual General Meeting/Proxy Form 29 Sep 2022 8:42AM $2.700 $2.250 fallen by 16.67%
$839 Update - Dividend/Distribution - IDX 26 Sep 2022 2:40PM $2.560 $2.250 fallen by 12.11%
$839 Change of Directors Interest Notice - Jacqueline Milne 8 Sep 2022 2:40PM $2.755 $2.250 fallen by 18.33%
$839 Application for quotation of securities - IDX 6 Sep 2022 9:35AM $2.840 $2.250 fallen by 20.77%
$839 Notification regarding unquoted securities - IDX 6 Sep 2022 9:31AM $2.840 $2.250 fallen by 20.77%

276 - 300 of 784 results

Page 12 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.